Adam Tomasi
President presso ALLAKOS INC.
Patrimonio netto: 779 011 $ in data 31/03/2024
Profilo
Il dottor Adam L. Tomasi è presidente e direttore operativo di Allakos, Inc. Fa parte del consiglio di amministrazione di Attune Pharmaceuticals, Inc. Il Dr. Tomasi è stato precedentemente impiegato come direttore scientifico presso la ZS Pharma, Inc., come principale presso la Alta Partners Management Corp., come chimico medicinale presso la Cytokinetics, Inc. e come chimico medicinale presso la Gilead Sciences, Inc. Ha conseguito la laurea presso l'Università della California, Berkeley, un MBA presso il MIT Sloan School of Management e un dottorato presso l'Università della California, Irvine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ALLAKOS, INC.
0.70% | 05/03/2024 | 618 263 ( 0.70% ) | 779 011 $ | 31/03/2024 |
Posizioni attive di Adam Tomasi
| Società | Posizione | Inizio |
|---|---|---|
| ALLAKOS INC. | President | 01/08/2019 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director/Board Member | - |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - |
Precedenti posizioni note di Adam Tomasi
| Società | Posizione | Fine |
|---|---|---|
| ZS PHARMA INC | Chief Tech/Sci/R&D Officer | 01/03/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Private Equity Investor | - |
Formazione di Adam Tomasi
| University of California, Berkeley | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ALLAKOS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
- Borsa valori
- Insiders
- Adam Tomasi
